PSI

OCT tops the list of the leading CROs in 3Q 2017

Thursday, November 2, 2017

According to the Synergy Research Group report, the most active CRO in the region were OCT, Quintiles, PSI, Synergy Research Group and IPHARMA. OCT has been working with the largest number of patients during this period. AbbVie tops the list of the leaders among foreign pharmaceutical companies, which initiated clinical trials in 3Q, while Biocad and Severnaya Zvezda were named the most active among Russian companies.

[Read More]

PSI, INC, Chiltern take top site ratings

Saturday, April 1, 2017

Investigators report their working relationships with CROs have become more effective during the past two years, according to a new CenterWatch survey, and nearly half said overall CRO performance, for the first time, matches that of sponsor companies.

[Read More]

PSI, INC Research, Chiltern best with sites

Wednesday, April 1, 2015

Contract research organizations (CROs) have become more effective in managing working relationships with investigative sites during the past two years, according to a new CenterWatch survey, yet the average CRO continues to fall below performance expectations in many of the areas investigators consider most critical for study success.

[Read More]

PSI opens Italian office

Wednesday, August 28, 2013

Global CRO PSI opened an operational office in Italy, expanding its presence in Europe and strengthening its ability to deliver global clinical trials. The office is located outside Milan.

[Read More]